Topical application of the HSP90 inhibitor 17-AAG reduces skin inflammation and partially restores microbial balance: implications for atopic dermatitis therapy.|https://dx.doi.org/10.1038/s41598-025-05307-3
Comparative genomic analysis of clinically relevant human skin-associated fungi.|https://dx.doi.org/10.21203/rs.3.rs-6700810/v1
